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Multicenter Evaluation of the Vitek MS Matrix-Assisted Laser
Desorption Ionization–Time of Flight Mass Spectrometry System for
Identification of Gram-Positive Aerobic Bacteria

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USAa; Department of Pathology & Immunology,
Washington University School of Medicine, St. Louis, Missouri, USAb; Barnes Jewish Hospital, St. Louis, Missouri, USAc; Department of Pathology and Laboratory Medicine,
North Shore-LIJ Health System Laboratories, Lake Success, New York, USAd; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine,
University of California, Los Angeles, Los Angeles, California, USAe; Department of Pathology and Laboratory Medicine, Hofstra North Shore-LIJ School of Medicine,
Hempstead, New York, USAf; Department of Clinical Pathology, Cleveland Clinic, Cleveland, Ohio, USAg

Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF) is gaining momentum as a tool for
bacterial identification in the clinical microbiology laboratory. Compared with conventional methods, this technology can more
readily and conveniently identify a wide range of organisms. Here, we report the findings from a multicenter study to evaluate
the Vitek MS v2.0 system (bioMérieux, Inc.) for the identification of aerobic Gram-positive bacteria. A total of 1,146 unique
isolates, representing 13 genera and 42 species, were analyzed, and results were compared to those obtained by nucleic acid
sequence-based identification as the reference method. For 1,063 of 1,146 isolates (92.8%), the Vitek MS provided a single
identification that was accurate to the species level. For an additional 31 isolates (2.7%), multiple possible identifications
were provided, all correct at the genus level. Mixed-genus or single-choice incorrect identifications were provided for 18
isolates (1.6%). Although no identification was obtained for 33 isolates (2.9%), there was no specific bacterial species for
which the Vitek MS consistently failed to provide identification. In a subset of 463 isolates representing commonly encountered important pathogens, 95% were accurately identified to the species level and there were no misidentifications.
Also, in all but one instance, the Vitek MS correctly differentiated Streptococcus pneumoniae from other viridans group
streptococci. The findings demonstrate that the Vitek MS system is highly accurate for the identification of Gram-positive
aerobic bacteria in the clinical laboratory setting.

I

n the clinical microbiology laboratory, bacteria are typically
identified using phenotypic and biochemical methods. These
methods are generally reliable but have several drawbacks. In particular, they can be time-consuming, sometimes taking several
days before a definitive identification can be reached. Furthermore, many are subjectively interpreted, rendering them susceptible to misinterpretation and requiring substantial training and
experience on the part of the technologist to establish and maintain competency. In the case of some Gram-positive bacteria, such
as the coagulase-negative staphylococci, the viridans group streptococci, and some enterococci, distinguishing one species from
another using these methods can be unreliable or overly complicated (1). Thus, many laboratories do not attempt to distinguish
among them, or do so only selectively.
Matrix-assisted laser desorption–ionization time of flight mass
spectrometry (MALDI-TOF MS) has the potential to address
these drawbacks. Proteomic analysis of bacteria by mass spectrometry can be performed as soon as colonies are isolated, often
in primary culture, and the analysis itself takes just a few minutes
(2–6). Thus, on average, routine bacterial identifications can be
obtained more than 30 hours earlier than identification by conventional methods (7). MALDI-TOF MS also provides equal or
superior accuracy compared with conventional phenotypic methods (8–10) and does not require subjective interpretation. Finally,
it can readily differentiate bacterial species that have similar phenotypic characteristics (11–19).
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There are only a few commercially available MALDI-TOF MS
systems used for identification of bacteria. Numerous studies have
described the performance of the two most common, the Bruker
Biotyper and the bioMérieux Vitek MS RUO, primarily compared
to phenotypic testing as the reference method (3, 4, 6, 8, 9, 13–23).
There are currently no published reports available on the performance of the Vitek MS IVD system, with its new method of spectral analysis and updated database (version 2.0). Here, we report
the findings of a large multicenter evaluation of the Vitek MS v2.0
system for the identification of Gram-positive aerobic bacteria in
which DNA sequence-based identification served as the reference
method.
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Organism identification using the Vitek MS v2.0 system. The Vitek
MS v2.0 system includes an OEM (original equipment manufacturer)labeled Shimadzu AXIMA Assurance mass spectrometer linked to a
reference database, referred to as Knowledge Base. During target interrogation, mass spectra within a range of 2,000 to 20,000 Da are
recorded in linear positive mode at a laser frequency of 50 Hz. For each
interrogation, laser shots at different positions within the target well
produce up to 100 mass profiles that are summed into a single, raw
mass spectrum. The spectrum is then processed by baseline correction,
denoising, and peak detection to identify well-defined peaks. The list
of these significant peaks is subjected to a proprietary process called
“mass binning” (see the supplemental material). The processed
(binned) data are used to query Knowledge Base to determine the
unknown’s taxonomic identity. These results are then provided in the
form of a single species-level (and sometimes subspecies-level) identification, a split (low discrimination) identification with up to four
species-level alternatives displayed, or no identification. For the present study, when a report of “no identification” was provided, or when
analysis of an isolate yielded absent or poor-quality spectra, the organism was reanalyzed a single time on a new target slide. Isolates yielding
split identifications were not reanalyzed. Additionally, isolates that
yielded a reference identification that is not included in the database
were excluded from analysis.
Reference method for bacterial identification. All study isolates were
sent to a centralized laboratory (MIDI Labs, Inc., Newark, DE) for nucleic
acid sequence-based identification. Sequencing of a 527-bp region within
the 16S rRNA gene was performed using universal 16S primers at positions 0005F and 0531R (MicroSeq system; Applied Biosystems, Carlsbad,
CA). The resulting sequence was run through the MicroSeq, GenBank,
and BiBi databases to determine the identity. In the event of a discrepancy
or low-discrimination result, or when no match was obtained using this
method, supplemental sequencing of a different gene target (sodA or
rpoB) and/or phenotypic testing was performed by bioMérieux, Inc.
(Durham, NC).
Analysis. The Vitek MS result was considered accurate to the species
level if a single identification was given and it matched that obtained by
the reference method. The Vitek MS result was considered correct to
the genus level if multiple alternative identifications, all from the same
genus, were reported and this matched the genus obtained by the
reference method. The Vitek MS result was considered incorrect if a
single identification was given that did not match (at some taxonomic
level) the result obtained with the reference method, when multiple
identifications of different genera were reported, or when multiple
identifications of the same genera were reported but did match the
genus of the reference method.

RESULTS

Overall results. A total of 1,146 unique, aerobic, Gram-positive
isolates was analyzed, representing 16 genera and 42 species. As
shown in Table 1, for 1,063 isolates (92.8%), the Vitek MS provided a single identification that matched at the species level the
identification obtained by the reference method. An additional 31
isolates (2.7%) were correctly identified to the genus level, meaning that the Vitek MS result included a split identification with
multiple alternative species all from the same genus, and the genus
in all cases matched that obtained by the reference method (Tables
1 and 2). For all but one of these isolates, the correct species was
listed among the alternate identifications provided (Table 2). A
total of 18 isolates were not accurately identified (1.6%) (Tables 1
and 3). This included seven isolates for which a single identification was provided that was accurate to the genus level but not the
species level, two isolates for which multiple identifications were
provided, all of which were incorrect to the genus level, and nine
isolates where multiple different genera were reported. In the later
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Study sites. The performance of the Vitek MS v2.0 system (bioMérieux,
Inc., Durham, NC) was assessed at five sites within the United States
(Boston, MA; St. Louis, MO; Los Angeles, CA; Lake Success, NY; and
Cleveland, OH). Prior to initiation of the study, operators at each site were
trained in target slide preparation, instrument use, and result review. Each
operator was required to demonstrate proficiency by successfully analyzing a masked panel of organisms consisting of 10 isolates representing
common aerobic and anaerobic Gram-positive and Gram-negative bacteria and yeasts. This study was approved by the human subject committees at the respective sites, when deemed necessary by their internal review
boards.
Bacterial isolates. Fresh isolates obtained in the course of routine
clinical work during the study period were collected and tested at each of
the study sites. Each site was responsible for analyzing a minimum of 10
isolates per species for a predetermined set of frequently encountered
organisms (Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus agalactiae, Streptococcus
pneumoniae, and Streptococcus pyogenes) and six isolates per species for a
predetermined set of less frequently encountered organisms (including
Enterococcus avium, Enterococcus casseliflavus, Enterococcus durans, Enterococcus gallinarum, Gardnerella vaginalis, Listeria monocytogenes, Micrococcus luteus/lylae, Staphylococcus capitis, Staphylococcus haemolyticus,
Staphylococcus hominis subsp. hominis, Staphylococcus lugdunensis, Staphylococcus saprophyticus, Staphylococcus simulans, Staphylococcus warneri,
Streptococcus anginosus, Streptococcus constellatus, Streptococcus dysgalactiae subsp. equisimilis, Streptococcus mitis/Streptococcus oralis, and Streptococcus sanguinis). In the event that a rarer organism, not included in the
list above, was tested, it was included in the study. If a site was unable to
obtain the minimum number of preselected species, additional testing of
frozen isolates obtained from their culture collections or provided by the
study sponsor was permitted. In all cases, cultures were incubated under
standard conditions for a minimum of 18 h at 35 to 37°C in ambient air
or with CO2 enrichment. Each isolate was analyzed on the Vitek MS
system within 72 h of visible growth either from the primary culture or
from a subculture. Subculturing was performed when colonies on the
primary culture plate were insufficiently isolated or for convenience to
allow batching. All subculturing was performed using tryptic soy agar
with 5% sheep blood (Remel, Lenexa, KS). More than 95% of the
isolates were tested after growth on this medium. Of the remaining
isolates, 53 were tested after growth on brucella agar supplemented
with 5% horse blood (Remel, Lenexa, KS), two after growth on chocolate agar (Remel, Lenexa, KS), and one after growth on human bloodTween bilayer (BD, Franklin Lakes, NJ). Frozen (archived) isolates
were serially subcultured twice on tryptic soy agar with 5% sheep
blood prior to analysis. Duplicate isolates of the same species from the
same patient were not included in the study.
Sample preparation for MALDI-TOF MS analysis. Isolated bacterial
colonies were applied to a single well of a disposable, barcode-labeled
target slide (Vitek MS-DS; bioMérieux, Inc.) using a 1.0-l loop, overlaid
with 1.0 l of a saturated solution of alpha-cyano-4-hydroxycinnamic
acid matrix in 50% acetonitrile and 2.5% trifluoroacetic acid (Vitek MSCHCA; bioMérieux, Inc.), and air dried. The same bacterial culture was
also used to set up a slide for Gram stain and prepare the organism for
shipment to a centralized laboratory for reference testing.
For instrument calibration, an Escherichia coli reference strain
(ATCC 8739) was transferred to designated wells on the target slide
using the procedure described above. For quality control purposes,
positive and negative controls were analyzed on each day of testing.
The positive control consisted of at least one of four quality control
organisms, including Staphylococcus aureus (ATCC 29213), Klebsiella
oxytoca (ATCC 13182), Pseudomonas aeruginosa (ATCC 10145), and
Enterobacter aerogenes (ATCC 13048). The negative control was matrix alone.

Evaluation of Vitek MS for Gram-Positive Aerobes

TABLE 1 Accuracy of organism identification using the Vitek MS v2.0 system
No. (%) with Vitek MS result
Multiple results all
correct to the
genus levelc

Single/multiple
incorrect
resultsd

Reference identification

No. of isolates
(fresh/archive/sponsor)a

Single result correct
to the species levelb

Common pathogens
Enterococcus faecalis
Enterococcus faecium
Staphylococcus aureus
Staphylococcus lugdunensis
Staphylococcus saprophyticus
Streptococcus pneumoniae
Streptococcus pyogenes
Streptococcus agalactiae
Listeria monocytogenes

463
62/6/0
41/16/0
59/2/0
25/8/0
26/9/0
45/6/0
45/10/0
53/5/0
12/33/0

442 (95)
66 (97)
57 (100)
60 (98)
33 (100)
32 (91)
49 (96)
53 (96)
58 (100)
34 (76)

4 (⬍1)

Other enterococci
Enterococcus avium
Enterococcus casseliflavus
Enterococcus durans
Enterococcus gallinarum

134
16/15/2
13/22/2
2/7/21
10/19/5

130 (97)
30 (91)
37 (100)
29 (97)
34 (100)

1 (⬍1)
1 (3)

Other coagulase-negative Staphylococci
Staphylococcus capitis
Staphylococcus cohnii
Staphylococcus epidermidis
Staphylococcus haemolyticus
Staphylococcus hominis
Staphylococcus schleiferi
Staphylococcus simulans
Staphylococcus warneri

249
26/8/0
2/0/0
78/10/0
23/15/0
17/3/1
1/1/0
11/14/6
14/7/12

240 (96)
32 (94)
2 (100)
86 (98)
38 (100)
21 (100)
2 (100)
31 (100)
28 (85)

Other streptococci
Streptococcus anginosus
Streptococcus constellatus
Streptococcus dysgalactiae
Streptococcus gallolyticus
Streptococcus infantarius
Streptococcus intermedius
Streptococcus mitis/oralis
Streptococcus mutans
Streptococcus salivarius
Streptococcus sanguinis

218
18/22/7
7/19/4
18/25/4
3/0/0
5/0/0
6/7/0
29/7/0
1/0/0
2/0/0
9/8/17

178 (82)
45 (96)
26 (86)
24 (51)
3 (100)
4 (100)
11 (85)
32 (86)

Other genera
Abiotrophia defective
Aerococcus viridans
Corynebacterium jeikeium
Gardnerella vaginalis
Gemella haemolysans
Granulicatella adiacens
Lactococcus garvieae
Lactococcus lactis
Leuconostoc mesenteroides
Micrococcus luteus/lylae
Rothia mucilaginosa

81
2/0/0
6/0/0
1/0/0
11/0/16
3/0/0
1/0/0
1/0/0
0/1/0
1/0/0
16/8/11
3/0/0

73 (90)
2 (100)
6 (100)
1 (100)
24 (89)
3 (100)
1 (100)
1 (100)
1 (100)
33 (94)
1 (33)

1 (33)

1 (3)
1 (33)

Total

1,146

1,063 (92.8)

31 (2.7)

18 (1.6)

No identification
17 (4)
2 (3)

3 (9)
2 (4)
2 (4)
4 (9)

7 (15)
1 (⬍1)

2 (1)
2 (6)

1 (3)

8 (3)
2 (6)

1 (⬍1)

2 (2)

25 (11)

4 (12)

1 (3)

4 (2)

11 (5)
2 (4)
2 (7)
3 (6)

1 (3)

3 (8)
1 (100)

2 (7)
20 (43)

2 (15)
1 (3)

2 (100)
31 (91)

3 (9)
1 (1)

5 (6)

2 (2)

3 (11)

1 (100)
1 (3)

33 (2.9)

a

Fresh isolates were those obtained during the normal clinical workflow; archived isolates were obtained from frozen stocks at one of the trial sites; sponsor isolates were obtained
from the sponsor’s frozen stocks. Sponsor-derived isolates were not used in the development of Knowledge Base.
b
The result was a single identification that matched the reference method to the species level.
c
The result was multiple possible identifications, all within the same genus, which matched (at the genus level) the identification obtained by the reference method.
d
The result was either a single identification that did not match the identification obtained by the reference method or multiple possible identifications that included more than one
genus.
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TABLE 2 Split identifications reported by the Vitek MS v2.0 system that were accurate to the genus level
No. of
isolates

Listeria monocytogenes
Listeria monocytogenes
Enterococcus avium
Streptococcus constellatus
Streptococcus dysgalactiae subsp. equisimilis
Streptococcus dysgalactiae subsp. equisimilis

3
1
1
2
1
19

Streptococcus intermedius
Streptococcus mitis
Rothia mucilaginosa

2
1
1

Total

31

cases, the correct species-level identification was included among
the alternatives. Finally, no identification was obtained for 33 isolates, all of which were represented in the database (2.9%) (Table
1). There was no specific bacterial species for which the Vitek MS
consistently failed.
Commonly encountered important pathogens. Given the
breadth of species analyzed in this study, some of which are rarely
encountered in the clinical microbiology laboratory, we considered the performance of the Vitek MS system for the identification
of a subset of commonly encountered and clinically important
Gram-positive bacteria (Table 1). This set of organisms was cho-

TABLE 3 Inaccurate results reported by the Vitek MS v2.0 system
Reference result
Single choice, incorrect to
species
Enterococcus durans
Staphylococcus
epidermidis
Staphylococcus
epidermidis
Staphylococcus warneri
Streptococcus sanguinis
Streptococcus sanguinis

No. of
isolates
7
1
1

E. faecium
S. hominis subsp. hominis

1

S. caprae

1
1
2

S. pasteuri
S. anginosus
S. mitis/oralis

Multiple choices, incorrect
to genus
Staphylococcus capitis

2

Staphylococcus capitis

1

Multiple choices, mixed
genera
Gardnerella vaginalis
Micrococcus lylae
Rothia mucilaginosa

9

Staphylococcus warneri
Streptococcus oralis

Total

2228

1

3
1
1
3
1

18

jcm.asm.org

Vitek MS results

Corynebacterium coyleae,
Riemerella anatipestifer
S. vestibularis, S. salivarius subsp.
salivarius

Bifidobacterium spp., G. vaginalis
M. luteus/lylae, Kocuria rosea
Alcaligenes faecalis subsp. faecalis,
R. mucilaginosa
Prevotella buccalis, S. warneri
S. mitis/oralis, S. parasanguinis,
Gemella morbillorum

Vitek MS identification
L. ivanovii, L. monocytogenes
L. ivanovii, L. monocytogenes, L. welshimeri
E. raffinosus, E. avium
S. anginosus, S. constellatus
S. equi subsp. zooepidemicus, S. equi subsp. equi
S. pyogenes, S. dysgalactiae subsp. equisimilis, S. dysgalactiae subsp.
dysgalactiae
S. constellatus, S. intermedius
S. mitis/oralis, S. pneumoniae
R. dentocariosa, R. mucilaginosa

sen prior to data analysis on the basis of being pathogenic and
commonly isolated from clinical specimens. Among the 463 isolates included in this group, 95% were accurately identified. The
level of accuracy was similar to that for all isolates combined (P ⫽
0.0557, Fisher exact test). Although 17 isolates (4%) within this
subset were not identified, there were no organisms within this
subgroup that were misidentified. Listeria monocytogenes was the
only organism within this group that was correctly identified to
the species level less than 90% of the time (Table 1). Seven of the 45
L. monocytogenes isolates (15%) were not identified, and an additional four (9%) were correctly identified to the genus but not the
species level (listed in Table 2).
Other enterococci, staphylococci, and streptococci. Among
the Gram-positive bacteria, the enterococci, staphylococci, and
streptococci are the most commonly encountered in the clinical
laboratory. Aside from the organisms included above, identification of these bacteria to the species level may not be feasible using
conventional methods due to the poor specificity and technical
challenges of these methods. With this in mind, we determined
the performance of the Vitek MS in accurately identifying these
groups of organisms (Table 1). Of the 134 enterococci, 130
(97%) were correctly identified to the species level. Similarly,
96% of the coagulase-negative staphylococci were correctly
identified to the species level (240 of 249). The accuracy was
lower for the streptococci, with 82% being identified to the
species level (178 of 218). In particular, only 51% of the S.
dysgalactiae isolates were correctly identified to the species
level (24 of 47). The remaining were either not identified or
correctly identified only to the genus level. Importantly, the
Vitek MS correctly distinguished S. pneumoniae from other S.
mitis group streptococci in all but one case. In this case, the
reference method identified an isolate as S. mitis, but the Vitek
MS reported a split identification between S. mitis/oralis and S.
pneumoniae. These data indicate that the Vitek MS can readily
provide species-level identifications for this challenging group
of organisms.
Other genera. The remaining isolates included in the study
represent an additional 10 genera. As shown in Table 1, the majority of these isolates were correctly identified to either the species
level (90%) or the genus level (1%). Six percent of the isolates in
this group were misidentified, including three G. vaginalis, one M.
luteus/lylae, and one Rothia mucilaginosa isolate. No identification
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was obtained for 2% of these isolates, including one isolate each of
Leuconostoc mesenteroides and M. luteus/lylae.
DISCUSSION
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The purpose of this study was to evaluate the new Vitek MS v2.0
MALDI-TOF mass spectrometry system for the identification of
Gram-positive aerobic bacteria in the clinical laboratory setting.
Compared to the reference method, the Vitek MS system provided
an accurate, species-level identification for more than 92% of the
isolates tested. This level of accuracy is similar to that obtained
using modern biochemical testing platforms (24–28) and other
MALDI-TOF MS systems (4, 6, 8, 12, 21, 23, 29, 30–33). The
advantage of this and other MALDI-TOF MS systems over conventional methods is the potential improvement in turnaround
time and reduction in reagent and labor costs (5, 7, 23, 34). This is
especially true for the less common species of Enterococcus, Staphylococcus, and Streptococcus, which can be difficult to identify at
the species level using conventional methods. Given the similar
level of accuracy among the commercially available MALDI-TOF
MS systems, factors including cost and ease of use will likely influence the choice of system.
Among the major commercial MALDI-TOF platforms, the instrument, sample preparation, and basic approach to signal acquisition are similar, but the approach to database building and analysis differs significantly (35). One approach uses a database of
reference mass spectra and a pattern matching algorithm (36). In
this approach, a “mass fingerprint” or peak list with mass-tocharge values and intensities is generated from an unknown sample. The mass fingerprint is then compared to a database of reference mass fingerprints, the mass signals and signal intensity (peak
height) are compared, and the closest matches are identified (35–
37). In contrast, the Vitek MS v2.0 uses a “bin matrix” approach to
determine the identity of an unknown organism in comparison to
the reference database (see the supplemental material). This analysis assigns added weight to species-specific peaks (35), a method
that has been shown to aid in differentiating between very similar
mass spectra derived from closely related species or subspecies
(36). Additional studies are required to determine whether this
difference in spectral analysis leads to improvements in the identification of bacterial species encountered in the clinical microbiology laboratory.
The Vitek MS v2.0 was able to reliably distinguish between S.
pneumoniae and other S. mitis group species. This appears to be an
advantage of this system in comparison to other MALDI-TOF MS
systems, which have been reported to misidentify S. mitis group
species (especially S. mitis, S. oralis, and S. pseudopneumoniae) as
S. pneumoniae (2, 8, 21, 23, 38–42). It was previously suggested
that this difficulty may stem from the extremely close relationship
of these species (35). However, it has been demonstrated that the
mass spectra of these organisms do contain characteristic peaks
that clearly distinguish them (43), and in a head-to-head comparison, an earlier version of the Vitek MS system was better able to
discriminate between these organisms than another commercial
MALDI-TOF MS platform (6). Follow up studies are necessary to
corroborate these findings.
This study has several strengths. First, it was a large multicenter
investigation with good geographic representation using primarily freshly obtained clinical isolates. Second, the study relied upon
nucleic acid sequence-based identification as the reference
method, which is especially unusual for a study of this size, due to

the cost associated with sequencing. Finally, very strict rules were
applied when isolates were tested. In particular, a single deposit
rather than multiple deposits of each isolate was spotted on the
target plate, and protein extraction was not performed. This is a
more stringent approach than has been adopted in other studies
(6, 11, 44). Further, repeated testing was not allowed when split
identifications were obtained. In this regard, the study findings
may underestimate the system’s true capabilities, as it is possible to
obtain a single, species-level identification by repeating the analysis after initially obtaining multiple identifications. Although the
breadth of organisms tested in this study was extensive, one limitation of the study was that there were several species for which
only a small number of isolates were analyzed, and for some of
these it was necessary to supplement the freshly collected isolates
with archived isolates.
In summary, the Vitek MS v2.0 is an accurate and userfriendly system for identifying Gram-positive aerobic bacteria
in the clinical laboratory. For some clinical microbiology laboratories, adoption of this technology is likely to improve service by providing species-level identification for the coagulasenegative staphylococci and the less common enterococci and
streptococci. It should be noted, however, that this technology
does not supersede the expertise of a trained microbiologist;
Gram staining and colony morphology are still a valuable part
of bacterial identification and can be used to identify errors
that may be overlooked by relying solely on the identification
result provided by the Vitek MS.
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